P45452 (MMP13_HUMAN) Homo sapiens (Human)

Collagenase 3 UniProtKBInterProSTRINGInteractive Modelling

471 aa; Sequence (Fasta)

Available Structures

49 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Human collagenase 3 (MMP-13) with peptide from pro-domain
4fu4
 Heteromer
25-471
2×ZN; 4×CA; 2×CL; 12×EDO;
Assess
Human collagenase 3 (MMP-13) full form with peptides from pro-domain
4g0d
 Heteromer
32-471
2×ZN; 5×CA; 1×CL; 11×PGO; 1×PEG;
Assess
Human collagenase 3 (MMP-13) full form with peptides from pro-domain
4fvl
 Heteromer
37-471
2×ZN; 5×CA; 2×CL; 3×GOL; 16×PGO; 5×PEG;
Assess
Flexibility and variability of TIMP binding: X-ray structure of the complex between collagenase-3/M…
2e2d
 Heteromer
P16368; 		104-268
2×ZN; 2×CA;
Assess
MMP13 Catalytic Domain Complexed with 4-{[1-methyl-2,4-dioxo-6-(3-phenylprop-1-yn-1-yl)-1,4-dihydro…
2ozr
homo-8-mer104-270
16×ZN; 24×CA; 8×GG1; 4×HAE;
Assess
MMP-13 complexed with 2-Napthylsulfonamide hydroxamic acid inhibitor
3zxh
homo-4-mer104-272
8×ZN; 14×CA; 4×E41; 10×GOL;
Assess
Crystal Structure of MMP-13 Complexed with Inhibitor 24f
3elm
homo-4-mer104-272
8×ZN; 14×CA; 4×24F;
Assess
MMP13 IN COMPLEX WITH A NOVEL SELECTIVE NON ZINC BINDING INHIBITOR CMPD22
4a7b
homo-4-mer104-272
2×3W5; 4×HAE; 4×GOL; 8×ZN; 8×CA; 4×NA; 2×3W4;
Assess
Mmp13 in complex with a reverse hydroxamate Zn-binder
4jp4
homo-2-mer104-272
4×ZN; 4×CA; 2×NA; 2×AZ4;
Assess
MMP13 in complex with a novel selective non zinc binding inhibitor
2yig
homo-2-mer104-272
2×5EL; 4×ZN; 4×CA; 3×NA;
Assess
X-RAY Co-structure of MMP-13 with 4-[({5-[2-(ethoxycarbonyl)-1H-indol-5-yl]-1-methyl-1H-pyrazol-3-y…
5bpa
homo-2-mer104-272
4×ZN; 6×CA; 2×4UF;
Assess
X-RAY Co-structure of MMP-13 with ethyl 5-carbamoyl-1H-indole-2-carboxylate
5bot
homo-2-mer104-272
2×4UM; 4×ZN; 6×CA;
Assess
Matrix metalloproteinase-13 complexed with non-zinc binding inhibitor
1xur
homo-2-mer104-272
4×ZN; 4×CA; 2×PB5;
Assess
MMP-13 in complex with a non zinc-chelating inhibitor
3i7g
homo-2-mer104-272
4×ZN; 6×CA; 2×FMT; 1×732;
Assess
Mmp13 in complex with a piperazine hydantoin ligand
4jpa
homo-2-mer104-272
4×ZN; 4×CA; 2×NA; 2×AZ6;
Assess
X-RAY Co-structure of MMP-13 with ethyl 5-(1-methyl-1H-imidazol-5-yl)-1H-indole-2-Carboxylate
5boy
homo-2-mer104-272
4×ZN; 6×CA; 2×4UE;
Assess
MMP-13 in complex with a non zinc-chelating inhibitor
3i7i
homo-2-mer104-272
4×ZN; 6×CA; 1×518;
Assess
MMP-13 in complex with the peptide IMISF
6hv2
homo-2-mer103-270
2×ZN; 3×CA; 1×GOL;
Assess
CRYSTAL STRUCTURE OF COLLAGENASE-3 (MMP-13) COMPLEXED TO A DIPHENYL-ETHER SULPHONE BASED HYDROXAMIC…
456c
homo-2-mer110-269
4×ZN; 2×CA; 2×CBP;
Assess
Matrix metalloproteinase-13 complexed with selective inhibitor compound (R)-17a
5uwm
homo-2-mer111-268
2×ZN; 3×CA; 1×8OA;
Assess
COLLAGENASE-3 (MMP-13) C-TERMINAL HEMOPEXIN-LIKE DOMAIN
1pex
monomer280-471
1×SO4; 2×CL; 2×CA;
Assess
SOLUTION STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN COLLAGENASE-3 (MMP-13) COMPLEXED TO A POTENT NO…
1eub
monomer104-274
2×ZN; 2×CA; 1×HAV; 1×3MP; 1×MSB;
Assess
Crystal structure of the catalytic domain of MMP-13 complexed with N-phenyl-4-((4H-1,2,4-triazol-3-…
5b5o
monomer104-273
2×ZN; 2×CA; 1×NA; 1×EDO; 1×WMM;
Assess
Crystal structure of the catalytic domain of MMP-13 complexed with N-(3-methoxybenzyl)-4-oxo-3,4-di…
3wv3
monomer104-273
2×ZN; 2×CA; 1×NA; 1×FMT; 1×EDO; 1×WLL;
Assess
Crystal structure of the catalytic domain of MMP-13 complexed with 4-(2-((6-fluoro-2-((3-methoxyben…
3wv1
monomer104-273
2×ZN; 2×CA; 1×NA; 1×FMT; 1×WHH;
Assess
Crystal structure of the catalytic domain of MMP-13 complexed with 4-oxo-N-(3-(2-(1H-1,2,4-triazol-…
5b5p
monomer104-272
2×ZN; 3×CA; 1×WNN;
Assess
Matrix metalloproteinase-13 complexed with non-zinc binding inhibitor
1xuc
monomer104-272
2×ZN; 2×CA; 1×PB3;
Assess
Matrix metalloproteinase-13 complexed with non-zinc binding inhibitor
1xud
monomer104-272
2×ZN; 2×CA; 1×PB4;
Assess
X-ray structure of MMP-13 in Complex with 4-(1,2,3-thiadiazol-4-yl)pyridine
7ju8
monomer104-272
2×ZN; 2×CA; 1×9DY; 6×FMT; 1×PGE;
Assess
Crystal structure of the catalytic domain of MMP-13 complexed with N-(3-methoxybenzyl)-4-oxo-3,4-di…
3wv2
monomer104-272
2×ZN; 2×CA; 1×NA; 1×WGG;
Assess
Human MMP13 in complex with L-glutamate motif inhibitor
3tvc
monomer104-272
2×ZN; 3×CA; 1×E3P; 3×PEG;
Assess
COLLAGENASE-3 (MMP-13) COMPLEXED TO A SULPHONE-BASED HYDROXAMIC ACID
830c
monomer104-271
2×ZN; 1×CA; 1×RS1;
Assess
Crystal structure of the catalytic domain of MMP-13 complexed with a potent pyrimidinetrione inhibi…
1you
monomer104-271
2×ZN; 1×CA; 2×SO4; 1×PFD;
Assess
Crystal structure analysis of the MMP13 catalytic domain in complex with specific inhibitor
2ow9
monomer104-270
2×ZN; 3×CA; 1×SO4; 1×SP6; 1×HAE;
Assess
Matrix metalloproteinase-13 complexed with selective inhibitor compound Q1
4l19
monomer104-269
3×ZN; 2×CA; 1×FMT; 2×1UA; 1×GOL;
Assess
Collagenase-3 (MMP-13) complexed to a hydroxamic acid inhibitor
2d1n
monomer104-269
4×ZN; 3×CA; 1×FA4;
Assess
Crystal structure of the catalytic domain of MMP-13 complexed with WAY-033
1ztq
monomer104-268
2×ZN; 3×CA; 1×033;
Assess
Crystal structure of the catalytic domain of MMP-13 complexed with WAY-344
2pjt
monomer104-268
2×ZN; 3×CA; 1×347;
Assess
Crystal structure of MMP-13 in complex with SC-78080
3kry
monomer104-267
2×ZN; 2×CA; 1×3KR;
Assess
Crystal Structure of Human MMP-13 complexed with a (pyridin-4-yl)-2H-tetrazole compound
3kek
monomer104-267
2×ZN; 3×CA; 1×3EK;
Assess
Crystal Structure of Human MMP-13 complexed with an Amino-2-indanol compound
3ljz
monomer104-267
2×CA; 2×ZN; 2×SO4; 1×LA3;
Assess
Matrix metalloproteinase-13 complexed with selective inhibitor compound (S)-10a
5uwk
monomer107-269
2×ZN; 3×CA; 1×8OM;
Assess
MMP-13 in complex with selective tetrazole core inhibitor
3o2x
monomer105-267
1×3O2; 2×ZN; 2×CA; 3×SO4; 1×EPE;
Assess
Crystal Structure of Human MMP-13 complexed with a phenyl-2H-tetrazole compound
3kec
monomer105-267
2×ZN; 3×CA; 2×SO4; 1×3KE; 1×HAE;
Assess
Crystal Structure of Human MMP-13 complexed with a (pyridin-4-yl)-2H-tetrazole compound
3kej
monomer104-266
2×ZN; 3×CA; 1×3EJ;
Assess
Matrix metalloproteinase-13 complexed with selective inhibitor compound 10d
5uwn
monomer109-269
2×ZN; 2×CA; 1×8O7; 2×SO4;
Assess
Matrix metalloproteinase-13 complexed with selective inhibitor compound (S)-17a
5uwl
monomer110-269
2×ZN; 3×CA; 1×8OJ;
Assess
SOLUTION STRUCTURE OF THE CATALYTIC FRAGMENT OF HUMAN COLLAGENASE-3 (MMP-13) COMPLEXED WITH A HYDRO…
1fm1
monomer110-267
2×ZN; 1×CA; 1×WAY;
Assess
SOLUTION STRUCTURE OF THE CATALYTIC FRAGMENT OF HUMAN COLLAGENASE-3 (MMP-13) COMPLEXED WITH A HYDRO…
1fls
monomer110-267
2×ZN; 1×CA; 1×WAY;
Assess

3 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
1su3.1.Amonomer0.7837-471
2×ZN;50.00
Assess
3ba0.1.Amonomer0.75113-471
2×ZN; 1×CA; 1×HAE;49.72
Assess
1l6j.1.Amonomer0.6137-257
1×ZN; 1×CA;49.27
Assess